UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

COVID-19 vaccination: The road ahead

Science (American Association for the Advancement of Science), 2022-03, Vol.375 (6585), p.1127-1132

2022

Link zum Volltext

Verfügbarkeit prüfen

What policy makers need to know about COVID-19 protective immunity

The Lancet (British edition), 2020-05, Vol.395 (10236), p.1527-1529

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunity to SARS-CoV-2 variants of concern

Science (American Association for the Advancement of Science), 2021-03, Vol.371 (6534), p.1103-1104

2021

Link zum Volltext

Verfügbarkeit prüfen

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?

Nature reviews. Immunology, 2021-12, Vol.21 (12), p.762

2021

Link zum Volltext

Verfügbarkeit prüfen

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

The Lancet (British edition), 2021-03, Vol.397 (10279), p.1057-1058

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

npj vaccines, 2021-05, Vol.6 (1), p.74-74, Article 74

2021

Link zum Volltext

Verfügbarkeit prüfen

Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosis

Nature communications, 2024-03, Vol.15 (1), p.2020-2020

2024

Link zum Volltext

Verfügbarkeit prüfen

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

Nature communications, 2023-08, Vol.14 (1), p.5139-5139, Article 5139

2023

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic therapy and outcome from immune-checkpoint inhibitors

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.287-8, Article 287

2019

Link zum Volltext

Verfügbarkeit prüfen

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy

Journal for immunotherapy of cancer, 2021-09, Vol.9 (9), p.e003311

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition

Cell reports. Medicine, 2021-05, Vol.2 (5), p.100286, Article 100286

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of SARS-CoV-2 reinfection after natural infection

The Lancet (British edition), 2021-03, Vol.397 (10280), p.1161-1163

2021

Link zum Volltext

Verfügbarkeit prüfen

Decoding the unknowns in long covid

BMJ (Online), 2021-02, Vol.372, p.n132

2021

Link zum Volltext

Verfügbarkeit prüfen

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

EBioMedicine, 2022-11, Vol.85, p.104293-104293, Article 104293

2022

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection

Science immunology, 2020-07, Vol.5 (49)

2020

Link zum Volltext

Verfügbarkeit prüfen

Hybrid Immunity Results in Enhanced and More Sustained Antibody Responses after the Second Sinovac-CoronaVac Dose in a Brazilian Cohort: DETECTCoV-19 Cohort

Viruses, 2023-09, Vol.15 (10), p.1987

2023

Link zum Volltext

Verfügbarkeit prüfen

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells

European journal of immunology, 2016-01, Vol.46 (1), p.185-191

2016

Link zum Volltext

Verfügbarkeit prüfen

BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis

Frontiers in immunology, 2021-12, Vol.12, p.767359-767359

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune Control of Burkholderia pseudomallei --Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes

Frontiers in immunology, 2018-03, Vol.9, p.484

2018

Link zum Volltext

Verfügbarkeit prüfen

Imprinted hybrid immunity against XBB reinfection

The Lancet infectious diseases, 2023-07, Vol.23 (7), p.764-765

2023

Link zum Volltext

Verfügbarkeit prüfen

Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants

Frontiers in immunology, 2020-02, Vol.11, p.185-185

2020

Link zum Volltext

Verfügbarkeit prüfen

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies

The lancet respiratory medicine, 2021-12, Vol.9 (12), p.1356-1358

2021

Link zum Volltext

Verfügbarkeit prüfen

Arming up against Omicron subvariants

Cell host & microbe, 2024-02, Vol.32 (2), p.147-148

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of HLA Polymorphism on the Immune Response to Bacillus Anthracis Protective Antigen in Vaccination versus Natural Infection

Vaccines (Basel), 2022-09, Vol.10 (10), p.1571

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(105)
Buchkapitel
(2)

Sprache

Englisch
(107)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Humans
(75)
Life Sciences & Biomedicine
(71)
Immunology
(35)
Covid-19
(27)
Male
(24)
Sars-Cov-2
(24)
Adult
(21)
Female
(21)
Vaccines
(21)
Infections
(20)
Animals
(19)
Severe Acute Respiratory Syndrome Coronavirus 2
(18)
Middle Aged
(17)
Mice
(16)
Antibodies
(15)
Antigens
(14)
Covid-19 Vaccines
(14)
General & Internal Medicine
(14)
Immunity
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

COVID-19 vaccination: The road ahead

What policy makers need to know about COVID-19 protective immunity

Immunity to SARS-CoV-2 variants of concern

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosis

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

Antibiotic therapy and outcome from immune-checkpoint inhibitors

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition

Risk of SARS-CoV-2 reinfection after natural infection

Decoding the unknowns in long covid

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection

Hybrid Immunity Results in Enhanced and More Sustained Antibody Responses after the Second Sinovac-CoronaVac Dose in a Brazilian Cohort: DETECTCoV-19 Cohort

Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells

BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis

Immune Control of Burkholderia pseudomallei --Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes

Imprinted hybrid immunity against XBB reinfection

Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies

Arming up against Omicron subvariants

Impact of HLA Polymorphism on the Immune Response to Bacillus Anthracis Protective Antigen in Vaccination versus Natural Infection

Suchergebnisse filtern